Delivering unprecedented treatment insights through the power of plaque composition analysis and high-resolution structural views.
The Makoto Intravascular Imaging System is an FDA-cleared imaging system indicated for the detection of lipid core plaque (LCP) and the identification of plaque and patients at increased risk of MACE. The system automatically quantifies the total lipid core in regions of interest and calculates a plaque’s Lipid Core Burden Index (LCBI). Multiple studies have confirmed that the LCB1 number can be used to evaluate patient and plaque risk of MACE, gauge the effectiveness of current therapies, and adjust future treatment plans.
The Makoto Intravascular Imaging System brings you valuable insights that no other system can.